Lotta; Luca Andrea

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lotta; Luca Andrea.The latest application filed is for "treatment of liver disease with ring finger protein 213 (rnf213) inhibitors".

Company Profile

0.1.9

Lotta; Luca Andrea - Tarrytown NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Liver Disease With Mitochondrial Glycerol-3-Phosphate Acyltransferase (GPAM) Inhibitors App 20220307032 - Lotta; Luca Andrea ; et al.	2022-09-29
Treatment Of Liver Disease With Ring Finger Protein 213 (RNF213) Inhibitors App 20220307033 - Lotta; Luca Andrea ; et al.	2022-09-29
Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors App 20220282253 - Verweij; Niek ; et al.	2022-09-08
Treatment of Liver Diseases With Cell Death Inducing DFFA Like Effector B (CIDEB) Inhibitors App 20220220474 - Verweij; Niek ; et al.	2022-07-14
Methods Of Treating Metabolic Disorders And Cardiovascular Disease With Inhibin Subunit Beta E (INHBE) Inhibitors App 20220184114 - Lotta; Luca Andrea ; et al.	2022-06-16
Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors Grant 11,359,246 - Lotta , et al. June 14, 2	2022-06-14
Treatment Of Sepsis With PCSK9 And LDLR Modulators App 20220064652 - Horowitz; Julie ; et al.	2022-03-03
Treatment Of Obesity In Subjects Having Variant Nucleic Acid Molecules Encoding Calcitonin Receptor (CALCR) App 20220049308 - Lotta; Luca Andrea ; et al.	2022-02-17
Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors App 20220042101 - Lotta; Luca Andrea ; et al.	2022-02-10
Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) Variants And Uses Thereof App 20210353709 - Lotta; Luca Andrea ; et al.	2021-11-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.